Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy

URN to cite this document:: urn:nbn:de:bvb:355-epub-525946
DOI to cite this document:: 10.5283/epub.52594

Hofbauer, Joshua ; Hauck, Andreas ; Matos, Carina

; Babl, Nathalie ; Decking, Sonja-Maria ; Rechenmacher, Michael

; Schulz, Christian

; Regotta, Sabine ; Mickler, Marion ; Haferkamp, Sebastian ; Siska, Peter J.

; Herr, Wolfgang ; Renner, Kathrin

; Kreutz, Marina

; Schnell, Annette

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 14 Jul 2022 07:07

Alternative links to fulltext:DOI Publisher Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Although the discovery of immune checkpoints was hailed as a major breakthrough in cancer therapy, generating a sufficient response to immunotherapy is still limited. Thus, the objective of this exploratory, hypothesis-generating study was to identify potentially novel peripheral biomarkers and discuss the possible predictive relevance of combining scarcely investigated metabolic and hormonal ...